Amarin Corp PLC
AMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000897448
No open-market purchases or sales by Amarin Corp PLC insiders were filed in the last 90 days; 80 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +12 vs. previous quarter
- 80
- 13F valueReported value at the end of Q2 2026
- $73.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding AMRN, Q2 2026
No superinvestor reported holding AMRN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Amarin Corp PLC insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Berg AaronPresident and CEO | PPurchase | +160.0K | $0.64 | +$102.4K | +24.8%805.4K after | |
| Jan 24, 2024 (view filing) | Jan 22 | 2 days | Holt PatrickPresident and CEO | PPurchase | +14.4K | $1.09 | +$15.7K | +4.8%314.4K after | |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Ketchum Steven BChief Scientific Officer | SSale | −34.1K | $0.79 | −$27.0K | −5.7%566.1K after | 10b5-1 |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Holt PatrickPresident and CEO | PPurchase | +300.0K | $1.04 | +$312.5K | New position300.0K after | 7 lots |
| Jun 15, 2022 (view filing) | Jun 13 | 2 days | Wold Olsen PerDirector | PPurchase | +55.0K | $1.69 | +$93.0K | +58.5%149.0K after | |
| Dec 16, 2021 (view filing) | Dec 14-15 | 2 days | Zakrzewski Joseph SDirector | PPurchase | +12.0K | $3.25 | +$39.0K | +6.5%196.5K after | 2 lots |
| Aug 13, 2021 (view filing) | Aug 12 | 1 day | Kalb Michael WayneSVP and CFO | SSale | −120.0K | $5.25 | −$630.0K | −36.9%205.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Amarin Corp PLC at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sarissa Capital Management LP | 1,673,395 | $26.7M | 15.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 720,984 | $11.5M | 0.01% | +84,215+13.2% | Added |
| Kynam Capital Management, LP | 532,982 | $8.50M | 0.47% | +60,600+12.8% | Added |
| Morgan Stanley | 223,617 | $3.56M | 0.00% | −69,555−23.7% | Reduced |
| Waterfront Wealth Inc. | 213,949 | $3.18M | 0.49% | +10,611+5.2% | Added |
| Brooklands Fund Management Ltd | 177,325 | $2.74M | 2.15% | +161,729+1,037.0% | Added |
| Eversept Partners, LP | 145,296 | $2.32M | 0.13% | −2,419−1.6% | Reduced |
| Millennium Management LLC | 115,808 | $1.85M | 0.00% | −184,728−61.5% | Reduced |
| Two Sigma Investments, LP | 100,511 | $1.60M | 0.00% | −7,031−6.5% | Reduced |
| Citadel Advisors LLC | 95,364 | $1.52M | 0.00% | +14,789+18.4% | Added |